◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Cerebras Systems Inc. Class A Common Stock (CBRS) EPS 2022–TTM
DATA UPDATED 2026-09-19
Cerebras Systems Inc. Class A Common Stock annual earnings per share (EPS) for fiscal 2025 was $1.10, compared with $-9.83 in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
CBRS Annual EPS
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|
| Earnings Per Share (EPS) | — | $1.10 | $-9.83 | $-0.61 | $-0.86 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
CBRS Quarterly EPS
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|
| Earnings Per Share (EPS) | — | $-0.22 | $-0.12 | $-0.10 | $1.44 | $-0.11 | $-0.49 | $-1.44 | $-0.71 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
EPS at Comparable Companies
- ARM EPS — Arm Holdings plc American Depositary Shares
- UMC EPS — United Microelectronics
- ALAB EPS — Astera Labs, Inc.
- STM EPS — STMicroelectronics NV ADR
- CRDO EPS — Credo Technology Group Holding Ltd
- GFS EPS — Globalfoundries Inc
More CBRS metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All CBRS financial statements → Interactive CBRS charts →
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.